Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference Life Science Investing
ABVC BioPharma Receives Additional US$100,000 Licensing Payment from OncoX BioPharma, Bringing Total Payments to US$695,950 Life Science Investing
Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London Life Science Investing
ChemDiv Extends CMC Services Collaboration for Ratutrelvir, a Potential Best-in-Class COVID-19 Therapeutic Advancing in Phase 2 Clinical Trials Life Science Investing
CytomX Therapeutics to Report Third Quarter 2025 Financial Results on November 6, 2025 Life Science Investing
ELAHERE® Receives Positive Reimbursement Recommendation by Canada's Drug Agency for Certain Types of Platinum-Resistant Ovarian Cancers Pharmaceutical Investing
